help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerhard, M.
Right arrow Articles by Prinz, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerhard, M.
Right arrow Articles by Prinz, C.
Endocrinology Vol. 142, No. 8 3663-3672
Copyright © 2001 by The Endocrine Society


ARTICLES

Gastrin Induces Expression and Promoter Activity of the Vesicular Monoamine Transporter Subtype 2

Markus Gerhard, Nina Neumayer, Elena Presecan-Siedel, Robert Zanner, Ernst Lengyel, Thorsten Cramer, Michael Höcker and Christian Prinz

II Medizinische Klinik (M.G., N.N., E.P.-S., R.Z., C.P.) and Department of Obstetrics and Gynecology (E.L.), Technical University, D-81675 Munich, Germany; and Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Universitätsklinikum Charite, Campus Virchow-Klinikum (T.C., M.H.), D-13353 Berlin, Germany

Address all correspondence and requests for reprints to: Dr. Christian Prinz, II Medizinische Klinik, Technische Universität München, Ismaninger Strasse 22, D-81675 Munich, Germany. E-mail: christian. prinz{at}lrz.tum.de


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Gastric enterochromaffin-like cells produce histamine in response to the antral hormone gastrin and accumulate the biogenic amine in secretory organelles via vesicular monoamine transporter subtype 2. The putative effects of gastrin on vesicular monoamine transporter subtype 2 expression and promoter activity are poorly understood. In the present study we used highly enriched rat enterochromaffin-like cells (purity, >90%) and rat pheochromocytoma cells stably transfected with a gastrin/cholecystokinin B receptor to investigate the expression and transcriptional regulation of vesicular monoamine transporter subtype 2. Stimulation of vesicular monoamine transporter subtype 2 mRNA and protein expression was observed in isolated enterochromaffin-like cells after 3- to 7-h incubation with gastrin (10-7 M), forskolin (10-5 M), or ionomycin (10-5 M). Deletion analysis of the rat vesicular monoamine transporter subtype 2 promoter defined the minimal promoter sequence necessary for full basal activity as a -121 bp segment upstream of exon 1 containing two Sp1 sites (-97 to -88 bp and -68 to -59 bp) and a cAMP-responsive element (-44 to -35 bp). Gastrin (10-7 M) stimulated extracellular signal related kinase1/2 phosphorylation, activated Sp1 and cAMP-responsive element-binding protein, and further induced activity of the complete rat vesicular monoamine transporter subtype 2 promoter (-800 bp) in gastrin/cholecystokinin B receptor cells. The -121-bp fragment was able to confer full gastrin responsiveness, and site-directed mutagenesis of the Sp1 and cAMP-responsive element motifs demonstrated their crucial importance for basal and inducible activities. Comparison of promoter activity of histidine decarboxylase, chromogranin A, or vesicular monoamine transporter subtype 2 in transfected cell lines revealed significant differences in basal and gastrin-stimulated activities. Our current study provides the first evidence that gastrin directly stimulates the expression and promoter activity of vesicular monoamine transporter subtype 2. Sp1 and cAMP-responsive element-binding protein recognition motifs located within 121 bp upstream of exon 1 appear to be indispensable for full basal and inducible promoter activities. Diverging effects of gastrin on histidine decarboxylase, chromogranin A, and vesicular monoamine transporter subtype 2 promoter may account for the coordinated synthesis and storage of histamine in this neuroendocrine cell type.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ENTEROCHROMAFFIN-LIKE (ECL) cells are histamine-containing neuroendocrine cells in the gastric epithelium that synthesize, store, and release histamine, thereby controlling the peripheral regulation of acid secretion (1). Histamine, following synthesis from histidine via histidine decarboxylase (HDC), is accumulated by a complex storage process in secretory vesicles together with acidic glycoproteins such as chromogranin A (CgA) (2). Previous studies have determined that histamine can be visualized in cytoplasmic vesicles using the weak base acridine orange (2, 3, 4, 5). This finding suggests that the storage of histamine in acidic vesicles depends on a proton-gradient established by a V-type adenosine triphosphatase (6) and on histamine uptake in secretory vesicles via a vesicular monoamine transporter (VMAT), similar to mechanisms detected in neuronal and chromaffin cell types (7, 8). The concentration of histamine in secretory organelles therefore appears to be regulated by the coordinated activation of histamine synthesis, the generation of matrix proteins such as CgA, and vesicular uptake via specific monoamine transporters.

Two VMAT subtypes have been characterized to date. Liu et al. (7, 8, 9, 10, 11, 12) showed that adrenal chromaffin, intestinal enterochromaffin, and neuronal cells store biogenic amines via activation of the VMAT-1. Erikson et al. (13, 14, 15, 16) isolated a different clone from the rat, termed VMAT-2, which was detected in basophilic leukocytes and gastric ECL cells. The rat and human VMAT-2 promoters have been cloned in previous studies (17, 18), but no physiological regulation of VMAT-2 expression by gastrointestinal hormones has been reported. Also, no direct evidence exists about the influence of gastric hormones on VMAT-2 promoter activity.

Gastrin, as a physiological stimulant of ECL cell function, may be a key hormone for the coordinated activation of histamine synthesis and storage. It has already been shown that gastrin induces histamine synthesis by stimulating HDC enzyme activity (4) and HDC mRNA expression (19). Gastrin increases the activity of the HDC promoter (20) and has also been shown to strongly induce the expression of the matrix protein CgA by activation of the CgA promoter (21). Therefore, it appears likely that gastrin exerts a functional synergy in ECL cells by controlling transcriptional regulation not only of HDC and CgA, but also of the VMAT-2 promoter.

Indeed, rats undergoing hypergastrinemia showed increased expression of VMAT-2 in the gastric mucosa, as determined by Northern blot reaction (22). These experiments also revealed an accompanying increase in HDC and CgA mRNA abundance during conditions of hypergastrinemia (22), suggesting a central role of gastrin for the transcriptional regulation of these genes. In the present study, we sought to determine whether this association reflects a direct effect of gastrin on VMAT-2 RNA and protein expression in ECL cells. Further, the effect of gastrin on the activity of the VMAT-2 promoter was investigated in PC-12 cells stably transfected with the gastrin/cholecystokinin B (CCK-B) receptor. Our current experiments yielded clear evidence that the promoter is responsive to gastrin stimulation, indicating the functional importance of this hormone for the coordinated regulation of histamine uptake in secretory vesicles.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Isolation and immunocytochemistry of rat gastric ECL cells
ECL cells were isolated as described previously (3, 4). ECL cells were identified by staining against HDC (3, 4). The percentage of ECL cells in the enriched fraction was >90%. Isolated ECL cells were incubated with antibodies against VMAT-1, VMAT-2 (1/500; Alpha Diagnostics, San Antonio, TX) or HDC (1/2000; Eurodiagnostica, Arnhem, The Netherlands) overnight at 4 C. After washing, cells were incubated with antirabbit secondary antibody conjugated to Alexa Fluor 488 (Molecular Probes, Inc., Eugene, OR) for 1 h at room temperature and processed for microscopy.

Stimulation of VMAT-2 mRNA expression in isolated ECL cells
Total RNA was isolated from enriched ECL cells using peqGOLDTriFast reagent (Peqlab, Erlangen, Germany). Primers were designed according to published sequences of the rat VMAT-2 mRNA (accession no. L00603). Sequences were: VMAT-2 sense, 5'-CTCTGTCTTCACTGGGACAGTCCG-3' (nucleotides 272–294); and VMAT-2 antisense, 5'-ACGGAAATCCAGACCACCAGACC-3' (nucleotides 447–470), yielding a product of 198 bp. PCR was performed using the TaqPCR Master Mix (QIAGEN, Hilden, Germany) and the following temperature cycle profile: 5 min at 94 C, followed by 30 cycles of 45 sec at 94 C, 55 sec at 58 C, 1 min at 72 C, and 10 min at 72 C. PCR products were subjected to horizontal agarose gel electrophoresis. Amplification products were eluted, subcloned into TOPO pCR2.1, and sequenced for verification. As control, PCR was performed simultaneously with primers specific for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), yielding a product of 950 bp. Primers were: GAPDH sense, 5'-TGAAGGTCGGTGTCAACGGATTTGGC-3'; and GAPDH antisense, 5'-CATGTAGGCCATGAGGTCCACCAC-3'.

Western blot analysis
Isolated ECL cells were stimulated with vehicle or the indicated stimulant. After rinsing cells in ice-cold PBS, cells were lysed in L-CAM lysis buffer (0.5 M NaCl, 0.1 M KCl, 0.1 M MgSo4, 0.1 M CaCl1, 0.1 M Triton X-100, 1 mM phenylmethylsulfonylfluoride) and sonicated. Protein amounts were determined by bicinchoninic acid kit (Pierce Chemical Co., Rockford, IL). Twenty micrograms of protein from each sample were boiled for 3 min in 4 x SDS gel loading buffer (1.5 M dithiothreitol, 6% SDS, 0.1% bromophenol blue, 40% glycerol, and 125 mM Tris, pH 6.8) and loaded. Proteins were separated by 12% SDS-PAGE and transferred to polyvinylidene difluoride membranes. The membranes were incubated with an anti-VMAT-2 antibody (1:500; Santa Cruz Biotechnology Inc., Heidelberg, Germany) overnight at 4 C. After four washes, membranes were overlaid with 1 µg/ml horseradish-peroxidase-labeled antirabbit IgG antibody (Amersham Pharmacia Biotech, Freiburg, Germany) for 1 h at room temperature, and the VMAT-2 band was detected at 50 kDa using the enhanced chemiluminescence system (Amersham Pharmacia Biotech). Densitometric analysis was performed using one-dimensional scan software.

Activation of Sp1 and cAMP response element (CRE)-binding protein (CREB) was investigated by preparing nuclear extracts from PC12-G cells after stimulation with gastrin. Antibodies against Sp1 (Santa Cruz Biotechnology Inc.; 1 µg/ml, recognizing p95 and p106) and the antiphospho-CREB (BIOMOL Research Laboratories, Heidelberg, Germany; 1:1000, recognizing Ser133) were applied overnight at 4 C, and detection was performed as described above.

Primer extension analysis
The transcriptional start site of the rat VMAT2 gene was determined by primer extension of VMAT2 mRNA isolated from PC12 cells stimulated with forskolin (10-5 M) or vehicle. To show that the same transcriptional start site is functionally important in our promoter constructs, cells were also transiently transfected with the plasmid containing the rat promoter cloned in-frame in pGL3 vector (rVMAT2) and a CREB expression plasmid (provided by Gerald Thiel, University of Erlangen, Erlangen, Germany). The 32P-labeled oligonucleotide (labeled with T4 polynucleotide kinase, New England Biolabs, Schwalbach, Germany; 3.55 x 106 cpm/pmol) used for mapping the rat VMAT2 promoter was the 25-mer 5'-CTCGCCTGTAACTGCGCGGTTATAG-3', complementary to the region +88 to +64 of the gene. Annealing was performed with 2–3 µg mRNA in 16 mM Tris (pH 8.3), 25 mM NaCl, and 1 mM MgCl2 [in the RT first strand buffer 5x (Life Technologies, Inc., Gaithersburg, MD) diluted 15 times] by incubation for 25 min at 65 C and subsequent cooling the mixture to 37 C before chilling them on ice. The extension reaction was performed in 1 x RT first strand buffer for 75 min at 42 C. To each annealing mixture the following reagents were added: 3 µl 0.1 M dithiothreitol, 1 µl 10 mM deoxy-NTP, and 0.5 µl RT Superscript II (Life Technologies, Inc.) in a final volume of 30 µl. After inactivation (10 min at 70 C), the excess RNA was digested with ribonuclease for 15 min at 37 C. Sequencing dyes and probes were denatured for 4 min at 70 C before being loaded on a 6% polyacrylamide/7 M urea gel.

Genomic cloning and construction of reporter constructs
Human VMAT2 promoter.A genomic human (h) VMAT2 fragment (4.1 kb) cloned in pGFP-1 vector was a gift from Dr. W. Xu (University College, London, UK). It contained 2.95 kb of 5'-flanking region of the hVMAT2 gene, exon 1 (100 bp), intron 1 (450 bp), and about 700 bp of exon 2. A 1.5-kb fragment was amplified by PCR and subcloned into pGL3 basic reporter vector yielding pGL-hVMAT-2-luc. Deletion mutants were generated by digestion with appropriate single cutting restriction enzymes giving fragments of -1115, -830, -309, -206, -120, -73, and +78 bp (numbers referring to the transcriptional start site).

Rat VMAT2 promoter.The rat promoter was cloned using the Genome Walker Kit (CLONTECH Laboratories, Inc., Heidelberg, Germany). Gene-specific primers (GSP) were located in exon II: GSP-1, 5'-TGTCCAGCAGCAGCGCAAGGAACACG-3'; and GSP-2,5'-GCACCAGATCGCTCAGGGCC-3'. Genomic PCR products were subcloned and sequenced. Putative recognition sequences for transcriptional start sites were identified using the TESS program. A 1125-bp fragment was subcloned in-frame into pGL3, yielding pGL-rVMAT-2-luc. 5'-Deletion constructs were generated by digestion with restriction enzymes, yielding fragments -808, -504, -177, -48, and +232 bp (numbers referring to the transcriptional start site). These fragments were further subjected to exonuclease III digestion (see below).

HDC and CgA promoter.The reporter constructs hHDC1.8kB-Luc and mCgA4.8kB-Luc containing the 1.8- or 4.8-kb sequences of human HDC and mouse CgA promoters were provided by Drs. T. C. Wang and D. T. O’Connor, respectively, and have been characterized previously (19, 21).

Dense scanning analysis
Exonuclease III digestion reporter constructs.pGL-rVMAT-2-luc was subjected to progressive unidirectional (5'->3') nested deletions by digestion with exonuclease III (Erase-a-Base System, Promega Corp., Heidelberg, Germany) according to the manufacturer’s instructions using the following restriction enzymes: for rVMAT2 -800, SacI-NheI, for the hVMAT2 -309, SacI-NheI and SacI-MluNI; for hVMAT2 -1115, KpnI-NheI and KpnI-PmlI (Roche Molecular Biochemicals, Mannheim, Germany).

PC12 culture and transfection studies.PC12 cells (European Collection of Cell Cultures, London, UK) were grown in RPMI 1640 medium supplemented with 2 mM L-glutamine, 10% horse serum, 5% FBS, and 1 x antibiotic solution (100 U/ml penicillin and 0.1 mg/ml streptomycin, Sigma, Munich, Germany). PC12 cells were transfected with a plasmid containing the entire coding sequence for the CCK-B/gastrin receptor (provided by Dr. Martin Beinborn, Massachusetts General Hospital, Boston, MA). For transfection experiments, PC12 cells were plated at a density of 1 x 106 cells/35-mm well and transfected using Cellfectin (QIAGEN, Hilden, Germany) and 1 µg/well pSV-ß-galactosidase control plasmid or 2 µg/well of reporter constructs. Selection media containing G418 were added after 3 days of incubation. Monoclonal cell lines were established by expanding single colonies. Stimulation with gastrin 10-7 M was performed overnight in serum-free medium.

Statistical analysis
Results are expressed as the mean ± SEM. Data were analyzed by t test or one-way ANOVA and subsequently with Newman-Keuls test. P < 0.05 was considered significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Immunocytochemistry of VMAT-1 and -2 in ECL cells
Initially, serial sections were obtained from the rat gastric mucosa and stained with different antibodies. Figure 1AGo represents a section of the gastric mucosa stained with a primary antibody specific against HDC. Numerous HDC-positive cells were detected at the basis of the gastric glands, corresponding to the location of ECL cells. Fig. 1BGo demonstrates a section of the mucosa stained with an antibody against VMAT-1, but only a few positive cells were detected. Thus, VMAT-1-positive cells appear to be rare in the rat gastric mucosa. In contrast, staining of sections with anti-VMAT-2 antibody (Fig. 1CGo) revealed numerous small cells at the basis of the glands, corresponding to the results with the HDC antibody and the location of ECL cells. As serial sections could not prove the colocalization of HDC and VMAT-2 in identical ECL cells, isolated and highly enriched ECL cells were prepared and stained.



View larger version (115K):
[in this window]
[in a new window]
 
Figure 1. Immunocytochemistry of VMAT-2 and HDC in ECL cells. A–C, Immunohistochemistry of the rat gastric mucosa using specific antibodies against HDC (A), VMAT-1 (B), and VMAT-2 (C). Numerous HDC-positive cells can be seen at the bases of gastric glands. Only a few cells show positive staining for VMAT-1, whereas VMAT-2-positive cells are far more frequent. Size bar for A–C, 100 µm. D and E, Isolated ECL cells from rat gastric mucosa prepared on cytospins (D) were stained with antibodies specific for HDC (E; 1:500). 21/23 ECL cells were identified by positive staining for HDC. Size bar for D and E, 10 µm. F and G, Isolated and 48-h cultured ECL cells stained with antibodies specific for HDC (F) and VMAT-2 (G). All HDC-positive cells were simultaneously VMAT-2 positive. Size bar for D–G, 10 µm.

 
As shown in Fig. 1Go, D and E, highly enriched ECL cells prepared as cytospins were used for immunocytochemistry. In Fig. 1DGo, a total of 23 cells can be seen, and 21 of them stain positively using an antibody against HDC (Fig. 1EGo). This finding was representative of the whole preparation. Thus, more than 90% of the cells were HDC positive and can therefore be regarded as ECL cells. Moreover, isolated and 48-h cultured cells were stained simultaneously with antibodies specific for HDC (Fig. 1FGo) and VMAT-2 (Fig. 1GGo). As demonstrated, all isolated ECL cells (100%) were found to express VMAT-2 simultaneously with HDC. Staining for VMAT-1 was not detected (not shown).

Stimulation of VMAT-2 mRNA and protein expression in ECL cells
Expression of VMAT-2 mRNA was determined using semiquantitative RT-PCR (Fig. 2AGo). Gastrin is known to exert its effect via calcium-signaling and plasmalemmal calcium entry. Therefore, gastrin and ionomycin were used as stimulants of VMAT-2 mRNA expression. A single PCR product of 198 bp was amplified and confirmed by sequencing. Gastrin (10-7 M; Fig. 2Go, left lanes 1–6) stimulated mRNA expression after 2–4 h of incubation, and the signal decreased after 5 h. Similarly, VMAT-2 mRNA expression was stimulated by ionomycin (10-5 M; Fig. 2Go, right lanes 1–6) after 3–5 h of incubation (Fig. 2AGo). Simultaneously (shown in the lower panel), PCR was also performed for GAPDH, yielding bands of identical intensities.



View larger version (83K):
[in this window]
[in a new window]
 
Figure 2. Stimulation of VMAT-2 gene and protein expression in ECL cells. A, RT-PCR of ECL cell mRNA. M, 100-bp ladder; b, basal (incubated with vehicle). Lanes 1–6, Incubation over 1–6 h with gastrin (10-7 M; left) or with ionomycin (10-5 M; right). Data are representative for three independent experiments. B, Left, Western blot analysis of VMAT-2 protein expression in ECL cells. Cells were incubated with gastrin (10-7 M), ionomycin (10-5 M), or forskolin (10-5 M) over 0, 3, 5, and 7 h. Right, Densitometric analysis of the bands during control or the stimulants. Band intensities were determined after 0, 3, 5, and 7 h of incubation and are presented as the mean ± SEM in a total of three independent experiments.

 
In analogy, protein expression was determined in ECL cells using Western blot analysis (Fig. 2BGo). A total of 20 µg protein was loaded onto each lane. Stimulation of VMAT-2 protein expression was observed with gastrin (10-7 M), ionomycin (10-5 M), and forskolin (10-5 M). As a control, actin expression was determined by Western blot from identical protein samples. Although the intensity of actin remained unchanged (98–104%), the intensity of VMAT-2 was stimulated by gastrin 2.5- and 4-fold after 5 and 7 h of incubation, respectively, which was a statistically significant difference (by unpaired t test, P < 0.05). Similarly, forskolin and ionomycin induced a statistically significant stimulation after 5 h of incubation (P < 0.05).

Determination of the transcriptional initiation site
The transcriptional start site of rat VMAT-2 mRNA was determined by primer extension analysis (Fig. 3Go). Before RNA extraction, PC12 cells were stimulated with forskolin (10-5M) or transfected with CREB expression plasmid and rVMAT-2. The transcriptional start site (+1) was located 8 bp further downstream as described in previous studies (17). One minor additional band was detected 18 bp further downstream, which might indicate a second transcriptional start site.



View larger version (140K):
[in this window]
[in a new window]
 
Figure 3. Determination of the transcriptional initiation site of the rVMAT2 gene. mRNA was isolated from PC12 cells, and transcriptional start sites (+1) were determined by primer extension analysis. PC12 cells were stimulated with forskolin (10-5 M; lane 1) or vehicle (lane 2), or, alternatively, PC12 cells were transiently transfected with CREB expression plasmid and rVMAT-2 (lane 3). Labeled oligonucleotides were used as negative controls (lane 4).

 
Organization and basal activity of the VMAT-2 promoter
To clone the rat and human VMAT-2 promoters, an 840-bp fragment (rat) and a 1123-bp fragment (human) containing exon I and intron I were subcloned in a pGL3 luciferase reporter vector. The complete promoter sequences up to -800 bp revealed a 35% homology. Both promoters contained conserved cAMP-responsive elements (CRE) at approximately -40 bp, NF{kappa}b sites located in intron I, and two Sp1 sites within -120 bp upstream of the transcription start site. The organization of these recognition motifs upstream is illustrated in Fig. 4AGo. After transfection into PC12 cells, promoter activity of different 5'-deletion mutants was measured by luciferase assay. As our initial studies ( Figs. 1–3GoGoGo) were performed with rat ECL cells, we used the rat promoter constructs for further detailed analysis. Deletional scanning of the rat VMAT-2 promoter was performed by repeated exonuclease III digestion. Fig. 4BGo illustrates the activity of these elements, defining the -121 bp fragment as the minimal sequence of the rVMAT-2 promoter exhibiting full basal activity. This region contains the CRE, AP2, and two Sp1 sites, as shown in Fig. 4AGo. To elucidate the importance of these elements for basal activity of the complete rat promoter (rVMAT-800), mutations were introduced into the CRE as well as the two Sp1 sites located upstream (as indicated in Fig. 4CGo, bottom line). Mutation of either Sp1 site reduced the promoter activity by approximately 50–60%, whereas mutation of the CRE reduced activity by 80%. Combined mutations of the CRE and either one of the adjacent Sp1 sites lead to a complete derogation of the basal promoter activity.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 4. Basal activity of the human and rat VMAT-2 promoter. A, Schematic illustration of the transcription factors present in the -140 bp 5'-flanking region of the rat and human VMAT-2 genes. B, 5'-Deletional scanning analysis of the rVMAT-2 promoter. Fragments of the rVMAT-2 promoter (indicated on the axis by increasing size) were transfected into PC12 cells, and basal luciferase activity was determined. C, Activity of rVMAT-2 promoter fragments after mutation of the Sp1 or CRE sites within the -120 bp region adjacent to exon 1, as indicated in the sequence below.

 
Construction and characterization of a gastrin-responsive cell line PC12-G
PC12 cells were stably transfected with the gastrin/CCK-B receptor. After expansion of monoclonal subcell lines, expression of the receptor was confirmed by RT-PCR (not shown). To test for functional activity of the receptor, gastrin-induced signal transduction was investigated by determining phosphorylation of extracellular signal related kinase (ERK)1/2 after stimulation with gastrin (10-7 M). As seen in Fig. 5AGo, gastrin induced phosphorylation of ERK1/2 within 2.5 min of incubation, and the signal was stronger than the positive control (PMA). Further, activation of Sp1 and p-CREB was demonstrated by Western blotting of nuclear extracts using Abs against Sp1 p95 and p106 and pCREB. Gastrin stimulation led to an increase in activated transcription factors after 5 min, with a maximum after 10 min (Fig. 5BGo).



View larger version (56K):
[in this window]
[in a new window]
 
Figure 5. Characterization of a gastrin-responsive cell line, PC12-G. A, Western blot performed with lysates from PC12-G cells. Cells were stimulated with vehicle or gastrin (10-7 M) as follows: lanes 1 and 2, basal (treated with vehicle); lanes 3–8, gastrin for 2.5 min (lane 3), 5 min (lane 4), 10 min (lane 5), 20 min (lane 6), 40 min (lane 7), or 60 min (lane 8); lane 9, PMA for 10 min. As shown in the upper lane, gastrin induced phosphorylation of ERK1/2 within 2.5 min, whereas the signal for unphosphorylated ERK1/2 remained unchanged (n = 3). B, Western blot performed with lysates from PC12-G cells and stained with antibodies specific for activated Sp1 or pCREB. Top, Western blot detection of Sp1 following stimulation with gastrin (10-7 M). Lane 1, Basal; lane 2, 5-min incubation; lane 3, 10-min incubation; lane 4, 15-min incubation; lane 5, 20-min incubation. Bottom, Detection of pCREB during gastrin stimulation and for an identical time period (representative for a total of three experiments).

 
Stimulation of the rat VMAT-2 promoter in PC12-G cells
To determine whether similar or distinct transcription factor recognition sites were responsible for stimulated compared with basal promoter activity, further deletion mutants of the rat promoter were created and investigated with regard to gastrin stimulation (10-7 M; Fig. 6AGo). Transfection of the complete rat VMAT-2 promoter (rVMAT-800) into PC12-G cells and consecutive stimulation with gastrin revealed a 3-fold induction of promoter activity. The minimal sequence necessary for complete stimulation of promoter activity by gastrin was found to contain the Sp1 and CRE site within 121 bp of the 5'-flanking region adjacent to exon 1. The -27 fragment failed to respond to gastrin treatment. To investigate the role of the transcription factor recognition sites present within the -121 bp fragment, we introduced mutations into both Sp1 sites and the CRE. As shown in Fig. 6BGo, mutation of either Sp1 site decreased gastrin responsiveness significantly. Mutation of the CRE led to a complete derogation of the gastrin effect.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 6. Determination of the gastrin-responsive sites in rat VMAT-2 promoter. A, Transfection of deletion mutants of the rVMAT-2 promoter in PC12-G cells and stimulation with gastrin (10-7 M). *1, P < 0.05, -800 bp fragment vs. pGL3 vector, both stimulated with gastrin; *2, P < 0.01, -121 bp fragment vs. pGL3 vector, both stimulated with gastrin; n.s., not significantly different from stimulation with vector only. B, Stimulation of mutated promoter fragments with gastrin (10-7 M). Mutations of the transcription factor-binding sites are indicated below. *1, P < 0.01, -121 bp vs. pGL3 vector, both stimulated with gastrin; *2, P < 0.01, Sp1m03 mutant vs. -121 bp fragment, both stimulated with gastrin; *3, P < 0.01, CRE mutant vs. -121 bp fragment, both stimulated with gastrin; n.s., not significantly different vs. stimulation of the -121 bp fragment. Statistical differences were calculated using one-way ANOVA and Newman-Keuls test (n = 4 independent experiments). Similar responses were obtained with a pGL3 vector that was mutated in internal Sp1 sites (pCGM vector).

 
Comparison of the HDC, CgA, and VMAT-2 promoter activities under basal and stimulated conditions
The complete HDC, CgA, and VMAT-2 promoter fragments were transfected into PC12-G cells, and luciferase activity was determined under basal (Fig. 7AGo) and stimulated (Fig. 7Go, B and C) conditions. As these promoters have been cloned into different reporter vectors, we normalized luciferase activity to the activity obtained with empty vectors. Basal promoter activity (unstimulated) was observed in PC12-G cells transfected with rVMAT-800, being 2- to 3-fold higher than cells transfected with the HDC or CgA promoter. Gastrin stimulated transcriptional activity of all three promoters, being highest in cells with CgA and 2- to 3-fold for VMAT-2 transfections.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 7. Comparison of the HDC, CgA, and VMAT-2 promoter activity under basal and stimulated conditions. The HDC, CgA, and VMAT-2 promoter fragments were transfected into PC12-G cells, and luciferase activity was determined under basal (A) and stimulated (B and C) conditions. Luciferase activity was normalized to the activity obtained with empty vectors. rVMAT-800 exhibited the highest level of basal promoter activity. Gastrin stimulated the transcriptional activity of all three promoters, with the strongest effect on the CgA promoter.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Vesicular monoamine transporters are important tools of neuroendocrine cells to achieve sequestration of synthesized monoamines in secretory organelles, enabling prompt responses to endocrine stimuli by regulated exocytosis. In gastric ECL cells, exocytosis is induced by the action of gastrin, leading to histamine release from cytoplasmic vesicles within a few minutes (2, 23). Gastrin, however, not only controls histamine secretion, but also histamine synthesis via activation of HDC expression (19, 24, 25, 26) and may also be a regulator for the transport of histamine into the vesicles. Generation of secretory vesicles in neuroendocrine cells is accompanied by the production and costorage of matrix proteins such as CgA (27, 28), which has been shown to be inducible by gastrin (21). This suggests the need for adequate transport mechanisms and capacities to enable storage of histamine in ECL cells, and a relatively high constitutive expression of the VMATs appears to be necessary for immediate storage of histamine after de novo synthesis. Furthermore, increased abundance of VMAT-2 is necessary during conditions of ECL cell hyperplasia and hypergastrinemia, a condition characterized by markedly increased ECL cell content. Therefore, it appears logical that gastrin meets such cellular requirements for increased transport capacities by regulating VMAT-2 expression and thereby coordinating histamine synthesis, generation of vesicular matrix proteins, and histamine storage in a functional synergy.

Using highly enriched ECL cells, we determined that gastrin is an effective stimulant of VMAT-2 mRNA and protein expression. This finding is new and provides the first evidence that this hormone directly regulates the expression of a monoamine transporter. Previous studies in rats described a stimulatory gastrin effect on VMAT-2 expression in vivo over several days (22). These studies, however, could not determine a direct effect of gastrin on ECL cell gene expression, nor was the early time course investigated (22). Thereby, our experiments underline that gastrin is a rather quick stimulus of VMAT-2 mRNA and protein expression within 3–7 h of incubation, enabling a prompt adaptation to increase transport capacities during conditions of hypergastrinemia.

These same findings were observed in part by Watson et al. (17), who found up-regulation of mRNA for VMAT2 and HDC in the pre-B cell line Ea3.123 after stimulation with ionomycin. As this cell line is not of neuroendocrine origin, we investigated the regulation of VMAT-2 promoter in PC12/pheochromocytoma cells. This cell line shows high endogenous expression of VMAT, providing the transcriptional machinery necessary for promoter activation.

The rat and human promoters were cloned, and sequences (17) exhibited a homology of 35%, which is relatively high for noncoding regions. A high similarity was also observed with the mouse VMAT-2 promoter (29). All promoters contain a conserved CRE, multiple Sp1 sites, and one AP2 recognition site positioned within the 140-bp 5'-flanking region of the transcriptional start site.

Using 5'-deletional scanning analysis, we found that a -121 bp rat fragment upstream of the transcriptional start site was able to confer full basal promoter activity (~10-fold activity compared with promoterless vector) in rats. The function of this minimal necessary element was characterized using dense scanning and mutational analysis of the rat promoter. This species was chosen for further investigation, because our physiological data were obtained in a rat model of ECL cells. As illustrated in Fig. 4Go, the two Sp1 sites (located -97 to -88 bp and -68 to -59 bp) and a CRE (-44 to -35 bp) were indispensable for full basal activity of the rVMAT-2 promoter. This was confirmed by mutation of each of these recognition sites, which led to a significant loss of the basal promoter activity, whereas combined mutation of CRE and the Sp1 completely abolished the basal promoter activity. Thus, a combined activation of CRE and Sp1 sites may be responsible for full constitutive activity of the VMAT-2 promoter. A high constitutive expression of VMAT-2 ensures a continuous availability of amine transporters in this cell type. Basal promoter activity appears to be maintained by activation of Sp1 and CRE recognition motifs adjacent to exon 1, which are highly evolutionary conserved in tandem in the rat, human, and mouse promoter (17, 18, 29).

Sp1 and CREB have also been identified as growth factor-inducible transcription factors. For example, PC12 cells treated with nerve growth factor react with phosphorylation of CREB at Ser133 (30, 31). Sp1 is activated by diverse signaling pathways after stimulation with growth factors in several tissues, especially by PKC-related pathways (32, 33, 34). This led us to the assumption that Sp1 and CREB are also gastrin-inducible transcription factors that could mediate a stimulatory effect on VMAT-2 expression. We therefore generated and characterized a gastrin-responsive cell line, PC12-G, to investigate the gastrin effect in detail. Indeed, incubation of PC12-G cells with gastrin induced ERK1/2 phosphorylation and Sp1 activation and activated the VMAT-2 promoter. The gastrin effect was obtained with the identical 121-bp fragment responsible for full basal activity. Mutation of the Sp1 sites or the CRE recognition motif decreased gastrin-stimulated promoter activity significantly, demonstrating that gastrin controls transcriptional regulation of VMAT-2 via Sp1 and CREB.

Transcriptional activation of the VMAT-2 and CgA promoter by gastrin might share several similarities. Previous studies reported that gastrin stimulated the CgA promoter in an Sp1- and CRE-dependent process (21). Although gastrin-induced transcriptional activation of CgA appears to be similar to transcriptional stimulation of VMAT-2, the gastrin effect on the HDC promoter is mediated by a distinct gastrin-responsive element within 27 bp upstream of the translational start site (35, 36).

Therefore, the complete promoters of HDC, CgA, or VMAT-2 were directly compared in PC12-G cells. Interestingly, significant differences regarding basal and stimulated promoter activities became evident; the VMAT-2 promoter had the highest activity under basal conditions and was 2.5-fold inducible by gastrin. This observation may reflect physiological conditions. Although there is a low abundance of histamine under basal conditions, stimulation with gastrin leads to increased histamine synthesis within 1–2 h of stimulation. Therefore, a high amount of basal VMAT-2 protein expression is required for the immediate transport of the amine into these vesicles. During hypergastrinemia, expression of this protein is adjusted to the increased cellular histamine content after 5–7 h of gastrin exposure, and therefore, expression of VMAT-2 is increased through a direct effect of gastrin.

In summary, VMAT-2 expression is clearly induced by gastrin in gastric ECL cells. Using a gastrin-responsive cell line as a model, we show that this induction is regulated on the transcriptional level, mainly involving Sp1 and CRE. Our results thereby underline that this hormone has pleiotropic effects, especially on ECL cells, controlling not only histamine release and synthesis, but also histamine storage. Gastrin acts as coordinating hormone, leading to a functional synergy of these enzymes, matrix proteins, and transporters, thereby adapting cellular functions to the differential physiological demands.


    Acknowledgments
 
We thank the following people for providing us with constructs: Prof. Dr. T. C. Wang (Boston, MA; HDC promoter), Prof. Dr. D. T. O’Connor (San Diego, CA; CgA promoter), Prof. M. Beinborn (Boston, MA; gastrin/CCK-B receptor), and Prof. W. Xu (Cambridge, UK; human VMAT-2 promoter).


    Footnotes
 
This work was supported by the Technical University of Germany (Kuratorium für Klinische Forschung; KKF) 8733151 TUM and KKF 8733156 TUM; C.P. is a recipient of the Heisenberg Program of the Deutsche Forschungsgemeinschaft (DFG) (Pr 411/7-1 and 411/9-1); M.H. was supported by the DFG (Ho1288/6-1).

Abbreviations: CgA, Chromogranin A; CCK-B, cholecystokinin-B; CRE, cAMP-responsive element; CREB, CRE binding protein; ECL, enterochromaffin-like; ERK, extracellular signal related kinase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GSP, gene-specific primer; HDC, histidine decarboxylase; h, human; r, rat; VMAT, vesicular monoamine transporter.

Received January 4, 2001.

Accepted for publication April 9, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Sachs G, Zeng N, Prinz C 1997 Physiology of isolated gastric endocrine cells. Annu Rev Physiol 59:243–256[CrossRef][Medline]
  2. Prinz C, Zanner R, Gerhard M, et al. 1999 The mechanism of histamine secretion from gastric enterochromaffin-like cells. Am J Physiol 277:C845–C855
  3. Prinz C, Kajimura M, Scott DR, et al. 1993 Histamine secretion from rat enterochromaffinlike cells. Gastroenterology 105:449–461[Medline]
  4. Prinz C, Scott DR, Hurwitz D, Helander HF, Sachs G 1994 Gastrin effects on isolated rat enterochromaffin-like cells in primary culture. Am J Physiol 267:G663–G675
  5. Scott DR, Hersey SJ, Prinz C, Sachs G 1993 Actions of antiulcer drugs. Science 262:1453–1454[Free Full Text]
  6. Forgac M 1989 Structure and function of vacuolar class of ATP-driven proton pumps. Physiol Rev 69:765–796[Free Full Text]
  7. Henry JP, Botton D, Sagne C, et al. 1994 Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules. J Exp Biol 196:251–262[Abstract/Free Full Text]
  8. Peter D, Liu Y, Sternini C, de GR, Brecha N, Edwards RH 1995 Differential expression of two vesicular monoamine transporters. J Neurosci 15:6179–6188[Abstract]
  9. Liu Y, Peter D, Roghani A, et al. 1992 A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70:539–551[CrossRef][Medline]
  10. Merickel A, Rosandich P, Peter D, Edwards RH 1995 Identification of residues involved in substrate recognition by a vesicular monoamine transporter. J Biol Chem 270:25798–25804[Abstract/Free Full Text]
  11. Nirenberg MJ, Liu Y, Peter D, Edwards RH, Pickel VM 1995 The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc Natl Acad Sci USA 92:8773–8777[Abstract/Free Full Text]
  12. Peter D, Finn JP, Klisak I, et al. 1993 Chromosomal localization of the human vesicular amine transporter genes. Genomics 18:720–723[CrossRef][Medline]
  13. Erickson JD, Eiden LE, Hoffman BJ 1992 Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci USA 89:10993–10997[Abstract/Free Full Text]
  14. Erickson JD, Eiden LE, Schafer MK, Weihe E 1995 Reserpine- and tetrabenazine-sensitive transport of 3H-histamine by the neuronal isoform of the vesicular monoamine transporter. J Mol Neurosci 6:277–287[Medline]
  15. Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E 1996 Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93:5166–5171[Abstract/Free Full Text]
  16. Weihe E, Schafer MK, Erickson JD, Eiden LE 1994 Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J Mol Neurosci 5:149–164[Medline]
  17. Watson F, Deavall DG, Macro JA, Kiernan R, Dimaline R 1999 Transcriptional activation of vesicular monoamine transporter 2 in the pre-B cell line Ea3.123. Biochem J 337:193–199
  18. Xu W, Liu L, Mooslehner K, Emson PC 1997 Structural organization of the human vesicular monoamine transporter type-2 gene and promoter analysis using the jelly fish green fluorescent protein as a reporter. Brain Res Mol Brain Res 45:41–49[Medline]
  19. Hocker M, Zhang Z, Fenstermacher DA, et al. 1996 Rat histidine decarboxylase promoter is regulated by gastrin through a protein kinase C pathway. Am J Physiol 270:G619–G633
  20. Hocker M, Zhang Z, Merchant JL, Wang TC 1997 Gastrin regulates the human histidine decarboxylase promoter through an AP-1-dependent mechanism. Am J Physiol 272:G822–G830
  21. Hocker M, Raychowdhury R, Plath T, et al. 1998 Sp1 and CREB mediate gastrin-dependent regulation of chromogranin A promoter activity in gastric carcinoma cells. J Biol Chem 273:34000–34007[Abstract/Free Full Text]
  22. Dimaline R, Struthers J 1996 Expression and regulation of a vesicular monoamine transporter in rat stomach: a putative histamine transporter. J Physiol 490:249–256[Medline]
  23. Hohne-Zell B, Galler A, Schepp W, Gratzl M, Prinz C 1997 Functional importance of synaptobrevin and SNAP-25 during exocytosis of histamine by rat gastric enterochromaffin-like cells. Endocrinology 138:5518–5526[Abstract/Free Full Text]
  24. Chen D, Monstein HJ, Nylander AG, et al. 1994 Acute responses of rat stomach enterochromaffinlike cells to gastrin: secretory activation and adaptation. Gastroenterology 107:18–27[Medline]
  25. Dimaline R, Sandvik AK 1991 Histidine decarboxylase gene expression in rat fundus is regulated by gastrin. FEBS Lett 281:20–22[CrossRef][Medline]
  26. Sandvik AK, Dimaline R, Marvik R, Brenna E, Waldum HL 1994 Gastrin regulates histidine decarboxylase activity and mRNA abundance in rat oxyntic mucosa. Am J Physiol 267:G254–G258
  27. O’Connor DT, Wu H, Gill BM, et al. 1994 Hormone storage vesicle proteins. Transcriptional basis of the widespread neuroendocrine expression of chromogranin A, and evidence of its diverse biological actions, intracellular and extracellular. Ann NY Acad Sci 733:36–45[Abstract]
  28. Tang K, Wu H, Mahata SK, et al. 1996 Stimulus-transcription coupling in pheochromocytoma cells. Promoter region-specific activation of chromogranin a biosynthesis. J Biol Chem 271:28382–28390[Abstract/Free Full Text]
  29. Takahashi N, Uhl G 1997 Murine vesicular monoamine transporter 2: molecular cloning and genomic structure. Brain Res Mol Brain Res 49:7–14[Medline]
  30. Ginty DD, Bonni A, Greenberg ME 1994 Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 77:713–725[CrossRef][Medline]
  31. Oshima RG, Abrams L, Kulesh D 1990 Activation of an intron enhancer within the keratin 18 gene by expression of c-fos and c-jun in undifferentiated F9 embryonal carcinoma cells. Genes Dev 4:835–848[Abstract/Free Full Text]
  32. Biggs JR, Kudlow JE, Kraft AS 1996 The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J Biol Chem 271:901–906[Abstract/Free Full Text]
  33. Daniel S, Kim KH 1996 Sp1 mediates glucose activation of the acetyl-CoA carboxylase promoter. J Biol Chem 271:1385–1392[Abstract/Free Full Text]
  34. Venepally P, Waterman MR 1995 Two Sp1-binding sites mediate cAMP-induced transcription of the bovine CYP11A gene through the protein kinase A signaling pathway. J Biol Chem 270:25402–25410[Abstract/Free Full Text]
  35. Hocker M, Henihan RJ, Rosewicz S, et al. 1997 Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through Raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells. J Biol Chem 272:27015–27024[Abstract/Free Full Text]
  36. Raychowdhury R, Zhang Z, Hocker M, Wang TC 1999 Activation of human histidine decarboxylase gene promoter activity by gastrin is mediated by two distinct nuclear factors. J Biol Chem 274:20961–20969[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
W. Ai, H. Zheng, X. Yang, Y. Liu, and T. C. Wang
Tip60 functions as a potential corepressor of KLF4 in regulation of HDC promoter activity
Nucleic Acids Res., September 25, 2007; 35(18): 6137 - 6149.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Catlow, H. L. Ashurst, A. Varro, and R. Dimaline
Identification of a Gastrin Response Element in the Vesicular Monoamine Transporter Type 2 Promoter and Requirement of 20 S Proteasome Subunits for Transcriptional Activity
J. Biol. Chem., June 8, 2007; 282(23): 17069 - 17077.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
R. N. Jain and L. C. Samuelson
Transcriptional profiling of gastrin-regulated genes in mouse stomach
Physiol Genomics, March 14, 2007; 29(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. Ai, Y. Liu, and T. C. Wang
Yin yang 1 (YY1) represses histidine decarboxylase gene expression with SREBP-1a in part through an upstream Sp1 site
Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1096 - G1104.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
R. N. Jain, C. S. Brunkan, C. S. Chew, and L. C. Samuelson
Gene expression profiling of gastrin target genes in parietal cells
Physiol Genomics, January 12, 2006; 24(2): 124 - 132.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Ai, Y. Liu, M. Langlois, and T. C. Wang
Kruppel-like Factor 4 (KLF4) Represses Histidine Decarboxylase Gene Expression through an Upstream Sp1 Site and Downstream Gastrin Responsive Elements
J. Biol. Chem., March 5, 2004; 279(10): 8684 - 8693.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Wang, A. B. Leiter, E. W. Englander, and G. H. Greeley Jr.
Insulin-Like Growth Factor I Increases Rat Peptide YY Promoter Activity through Sp1 Binding Sites
Endocrinology, February 1, 2004; 145(2): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Raychowdhury, G. Schafer, J. Fleming, S. Rosewicz, B. Wiedenmann, T. C. Wang, and M. Hocker
Interaction of Early Growth Response Protein 1 (Egr-1), Specificity Protein 1 (Sp1), and Cyclic Adenosine 3'5'-Monophosphate Response Element Binding Protein (CREB) at a Proximal Response Element Is Critical for Gastrin-Dependent Activation of the Chromogranin A Promoter
Mol. Endocrinol., December 1, 2002; 16(12): 2802 - 2818.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerhard, M.
Right arrow Articles by Prinz, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerhard, M.
Right arrow Articles by Prinz, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals